Showing results (21-30 of 683) with videos related to
Sort By:
Pageof 69
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with non-resectable lung cancerJ Vibe-Petersen, N Tvede, M Diamant, et al.Scandinavian Journal of Rheumatology|January 1, 1991
Elastolytic activity of human monocytes from synovial fluid and blood of patients with arthritis. Relations to levels of interleukin 6 and soluble interleukin 2 receptorH S Jensen, N Tvede, M Diamant, et al.Scandinavian Journal of Immunology|July 1, 1987
Selective modulation of the CD4 molecular complex by Pseudomonas aeruginosa alkaline protease and elastaseB K Pedersen, A Kharazmi, T G Theander, et al.Infection and Immunity|July 1, 1988
Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteasesT G Theander, A Kharazmi, B K Pedersen, et al.Scandinavian Journal of Rheumatology|January 1, 1995
Cytokine autoantibodies in rheumatoid arthritisM B Hansen, V Andersen, K Rohde, et al.Acta Pathologica Et Microbiologica Scandinavica. Section C, Immunology|December 1, 1976
Some physicochemical properties of human leucocyte migration inhibitory factor (LIF)K BendtzenScandinavian Journal of Immunology|October 1, 1981
Induction of antigen-specific immunological unresponsiveness by inhibitors of human lymphocyte-activating factorK BendtzenJournal of Clinical & Laboratory Immunology|April 1, 1979
Determination of the human lymphokine leukocyte migration inhibitory factor (LIF) by a sensitive radioenzymatic assay. Inhibitory effect of cGMP on the esterolytic activity of highly purified LIFK BendtzenScandinavian Journal of Immunology|January 1, 1977
Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitorsK BendtzenScandinavian Journal of Immunology|January 1, 1978
Human leucocyte migration inhibitory factor (LIF). V. Specific regulation of the lymphokine serine protease activity by 3',5'-cGMP and, possibly, 2',3'-cCMPK BendtzenPageof 69